$1.94
+0.00 (+0.00%)
Open$1.93
Previous Close$1.94
Day High$1.97
Day Low$1.87
52W High$12.23
52W Low$1.50
Volume—
Avg Volume130.7K
Market Cap26.25M
P/E Ratio—
EPS$-6.84
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+2,153.6% upside
Current
$1.94
$1.94
Target
$43.72
$43.72
$35.70
$43.72 avg
$58.20
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.37M | 4.18M | 3.97M |
| Net Income | -85,630,459 | -1,151,363 | -1,086,006 |
| Profit Margin | -16,993.3% | -27.6% | -27.4% |
| EBITDA | -85,783,356 | -1,394,086 | -1,159,340 |
| Free Cash Flow | — | -921,744 | -1,324,564 |
| Rev Growth | — | +11.5% | +10.2% |
| Debt/Equity | — | 0.72 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |